Latest Research Reports

Novavax driving to achieve significant market presence in respiratory complications market

Novavax driving to achieve significant market presence in respiratory complications market

Development of PARP inhibitors for ovarian and breast cancer is equally extensive

A large number of clinical trials evaluating inhibitors of the enzyme poly ADP ribose polymerase (PARP) in breast and ovarian cancers are either ongoing or completed....

Development of PARP inhibitors for ovarian and breast cancer is equally extensive